Wu Zhenzhu, Li Jie, Fang Peipei, Pan Chenwei, Chen Yi
Department of Infectious Disease, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, 325000, People's Republic of China.
Department of Gastroenterology, Wenzhou People's Hospital, Wenzhou, Zhejiang, 325000, People's Republic of China.
Infect Drug Resist. 2024 Apr 23;17:1589-1598. doi: 10.2147/IDR.S447506. eCollection 2024.
The prevalence of pyogenic liver abscess (PLA) is increasing worldwide. However, evaluation on its economic burden is still lack.
A retrospective study that included all patients identified PLA from 2017 to 2020 was conducted. Clinical information and hospital costs were collected through the electronic medical records. We evaluated the economic burden using disability-adjusted life years (DALYs). Differences in socioeconomic burdens between -caused liver abscesses (KPLA) and non--caused liver abscesses (non-KPLA) were compared.
We found 327 patients identified PLA in the study, including 146 with KPLA and 181 with non-KPLA. The demographic characteristics, median hospital stay, severity, and in-hospital mortality were similar between the two groups. The median total in-hospital cost was higher in the non-KPLA than in the KPLA group, although no statistical difference was found ($3607.2 vs $3424.6; P = 0.446). The median DALY loss was significantly higher in the KPLA than in the non-KPLA group [1.49 (0.97-2.30) vs 1.27 (0.87-1.89); P = 0.033)], and male patients presented a higher average DALY loss than female patients. KPLA had a substantially greater median indirect economic loss than the non-KPLA group [$1442.8 (915.9-17,221.5) vs $1232.5 (764.6-15,473.0); P = 0.028], and indirect economic loss exhibited a significant increase from 2017 to 2020 in patients with PLA. No differences were found in the socioeconomic burden between the two groups [$8019.6 (4200.3-21,832.1) vs $7436.4 (4023.2-19,063.9); P = 0.172].
The economic burden of PLA is significant, particularly in patients with KP. Patients with KPLA experienced increased DALY loss and indirect economic loss than non-KPLA. PLA must be prioritized as the indirect economic burden rises annually.
化脓性肝脓肿(PLA)在全球范围内的患病率正在上升。然而,对其经济负担的评估仍然缺乏。
进行了一项回顾性研究,纳入了2017年至2020年期间所有确诊为PLA的患者。通过电子病历收集临床信息和住院费用。我们使用伤残调整生命年(DALYs)评估经济负担。比较了由[具体病因不明,原文此处有缺失]引起的肝脓肿(KPLA)和非[具体病因不明,原文此处有缺失]引起的肝脓肿(非KPLA)之间的社会经济负担差异。
我们在研究中发现327例确诊为PLA的患者,其中146例为KPLA,181例为非KPLA。两组之间的人口统计学特征、中位住院时间、严重程度和院内死亡率相似。非KPLA组的中位住院总费用高于KPLA组,尽管未发现统计学差异(3607.2美元对3424.6美元;P = 0.446)。KPLA组的中位DALY损失显著高于非KPLA组[1.49(0.97 - 2.30)对1.27(0.8